ライフサイエンスコーパス: docosapentaenoic acid

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 ference was that adrenic acid (22:4 n-6) and docosapentaenoic acid (22:5 n-6), both metabolites of ar

2 d with 1-14C- or 3-14C-labeled 7,10,13,16,19-docosapentaenoic acid (22:5(n-3)), [1-14C]22:6(n-3), [3-

3 erythrocyte total phospholipid ALA, EPA, and docosapentaenoic acid (22:5n-3) fatty acid content.

4 The PUFA docosapentaenoic acid (22:5n-3) was not significantly as

5 ons of eicosapentaenoic acid (20:5n-3; EPA), docosapentaenoic acid (22:5n-3; DPA), and docosahexaenoi

6 f DHA and significantly higher levels of n-6 docosapentaenoic acid (22:5n-6) in their ROS than defici

7 DHA was replaced by docosapentaenoic acid (22:5n-6), an n-6 FA.

8 ecursors, results in replacement of DHA with docosapentaenoic acid (22:5n6, DPA), an omega-6 fatty ac

9 cosapentaenoic acid + docosahexaenoic acid + docosapentaenoic acid + alpha-linolenic acid) was associ

10 r profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

11 e predominantly eicosapentaenoic acid (EPA), docosapentaenoic acid, and docosahexaenoic acid (DHA).

12 No associations between total n-3 PUFA, docosapentaenoic acid, and docosahexaenoic acid and 5-y

13 hospholipid levels of eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid were mea

14 individual n-3 PUFAs eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid were obs

15 specifically those of eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid, were as

16 n-3 [VLC n-3; sum of eicosapentaenoic acid, docosapentaenoic acid, and docosahexaenoic acid] and alp

17 nsaturated fatty acids eicosapentanoic acid, docosapentaenoic acid, and docosahexaenoic acid] was 1.1

18 were associated with eicosapentaenoic acid, docosapentaenoic acid, arachidonic acid, CLA:9c11t and g

19 o the structural elucidation of hydroxylated docosapentaenoic acid-containing diacyl-phosphatidylchol

20 as sufficient to elevate erythrocyte EPA and docosapentaenoic acid content, which shows the effective

21 le of total n-3 PUFAs (eicosapentaenoic acid+docosapentaenoic acid+docosahexaenoic acid) levels was 0

22 g eicosapentaenoic acid (EPA) (20:5omega-3), docosapentaenoic acid (DPA) (22:5omega-3), and docosahex

23 were not associated with HF, whereas plasma docosapentaenoic acid (DPA) showed a nonlinear inverse r

24 In resident peritoneal macrophages, docosapentaenoic acid (DPA) was responsible for cyclooxy

25 onance (NMR), alpha-linolenic acid (ALA) and docosapentaenoic acid (DPA) were rapidly cleaved by PPL

26 , 0.40 (0.20, 0.82; P for trend = 0.004) for docosapentaenoic acid (DPA), and 0.46 (0.18, 1.16; P for

27 oic acid (DHA), eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and arachidonic acid (AA) i

28 acids, the EGCG molecule was esterified with docosapentaenoic acid (DPA), upon which a mixture of est

29 O increased (P < 0.001) plasma ALA, EPA, and docosapentaenoic acid (DPA), with no change in DHA compa

30 n (LC) n-3 polyunsaturated fatty acid (PUFA) docosapentaenoic acid (DPA).

31 Plasma (2)H(5)-EPA and (2)H(5)-22:5n-3 [docosapentaenoic acid (DPA)] efficiently converted to (2

32 y an alcohol at C13 and are derived from n-3 docosapentaenoic acid (DPA, C22:5).

33 % docosahexaenoic acid (DHA) and 11% omega-6 docosapentaenoic acid (DPA-n6) after partial hydrolysis

34 n-6 fatty acids, either arachidonic acid or docosapentaenoic acid (DPAn-6), diminished the efficacy

35 Eicosapentaenoic acid and docosapentaenoic acid levels were not significantly asso

36 log10(Bayes Factor) = 6.16) and of PPT2 with docosapentaenoic acid (log10(Bayes Factor) = 6.24) were

37 D1(n-3 DPA)), 7,14-dihydroxy-8,10,12,16Z,19Z-docosapentaenoic acid (MaR1(n-3 DPA)) and related bioact

38 dihomo-GLA, docosatetraenoic acid (DTA), and docosapentaenoic acid (n6-DPA), with HRs between 1.13 to

39 increases over time in breast-milk 22:5n-3 (docosapentaenoic acid, or DPA) (P < 0.02), plasma DPA (P

40 es include 7,8,17-trihydroxy-9,11,13,15E,19Z-docosapentaenoic acid (RvD1(n-3 DPA)), 7,14-dihydroxy-8,

41 Interactions were also observed for docosapentaenoic acid, total n-3 PUFAs, and arachidonic

42 trations in healthy women and that increased docosapentaenoic acid was associated with a lower risk o

43 cenic, alpha-linolenic, eicosapentaenoic and docosapentaenoic acids were higher in cows with a low pr

44 Docosapentaenoic acid, which replaces DHA during n-3 fat

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。